Nasdaq-100 Index (NDX.NAS100)

Cours de clôture: 19 433.00 (+218.16), 25. avr 2025
Conclusion légèrement positive

Bas risk

Automatic technical analysis. Moyen terme, 25. avr 2025

Nasdaq-100 Index a débordé du canal haussier à la baisse. Cela indique dans un premier temps, un taux de croissance plus faible ou le début d'un développement plus horizontal. Le titre a franchi un niveau de résistance sur le court terme et la stratégie de trading range court terme a donné un signal d'achat. L'indice rencontre du support à environ 18300 points et de la résistance à environ 20600 points. L'indice est généralement considéré comme légèrement positif technique pour moyen long terme.

Recommendation one to six months: Conclusion légèrement positive (Score: 40)

Période  
Vol.bal. Volatilité Liquidité +/- %
1 jour-0.98%0.00+1.14%
5 jours0.003.27%0.00+6.43%
22 jours0.008.05%0.00-4.22%
66 jours0.0015.32%0.00-9.89%

More analyses of Nasdaq-100 Index

chart Nasdaq-100 Index (NDX) Chandeliers 22 Days
Candlesticks
chart Nasdaq-100 Index (NDX) Court terme
Court terme: Positif
chart Nasdaq-100 Index (NDX) Moyen terme
Moyen terme: Conclusion légèrement positive
chart Nasdaq-100 Index (NDX) Long terme
Long terme : Conclusion légèrement positive
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.